BAMCO Inc’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-50,500
| Closed | -$1.04M | – | 335 |
|
2024
Q1 | $1.04M | Hold |
50,500
| – | – | ﹤0.01% | 304 |
|
2023
Q4 | $1.08M | Hold |
50,500
| – | – | ﹤0.01% | 301 |
|
2023
Q3 | $1.04M | Hold |
50,500
| – | – | ﹤0.01% | 297 |
|
2023
Q2 | $1.49M | Hold |
50,500
| – | – | ﹤0.01% | 302 |
|
2023
Q1 | $1.16M | Sell |
50,500
-213,756
| -81% | -$4.92M | ﹤0.01% | 318 |
|
2022
Q4 | $7.35M | Sell |
264,256
-10,606
| -4% | -$295K | 0.02% | 245 |
|
2022
Q3 | $8.44M | Sell |
274,862
-843
| -0.3% | -$25.9K | 0.03% | 244 |
|
2022
Q2 | $8.11M | Sell |
275,705
-379,643
| -58% | -$11.2M | 0.03% | 258 |
|
2022
Q1 | $21.1M | Sell |
655,348
-340,956
| -34% | -$11M | 0.05% | 226 |
|
2021
Q4 | $44.4M | Sell |
996,304
-131,615
| -12% | -$5.87M | 0.09% | 176 |
|
2021
Q3 | $56.9M | Sell |
1,127,919
-127,305
| -10% | -$6.42M | 0.13% | 144 |
|
2021
Q2 | $98.5M | Buy |
1,255,224
+45,400
| +4% | +$3.56M | 0.23% | 97 |
|
2021
Q1 | $69.1M | Buy |
1,209,824
+146,418
| +14% | +$8.36M | 0.17% | 124 |
|
2020
Q4 | $89.1M | Buy |
1,063,406
+105,200
| +11% | +$8.81M | 0.22% | 95 |
|
2020
Q3 | $34.3M | Buy |
958,206
+5,249
| +0.6% | +$188K | 0.11% | 145 |
|
2020
Q2 | $23M | Hold |
952,957
| – | – | 0.08% | 162 |
|
2020
Q1 | $16.7M | Hold |
952,957
| – | – | 0.08% | 152 |
|
2019
Q4 | $16.6M | Sell |
952,957
-31,705
| -3% | -$552K | 0.06% | 176 |
|
2019
Q3 | $15.1M | Hold |
984,662
| – | – | 0.06% | 178 |
|
2019
Q2 | $20.4M | Hold |
984,662
| – | – | 0.08% | 171 |
|
2019
Q1 | $22.9M | Buy |
984,662
+760
| +0.1% | +$17.6K | 0.1% | 164 |
|
2018
Q4 | $20.3M | Buy |
983,902
+28,500
| +3% | +$589K | 0.1% | 162 |
|
2018
Q3 | $20.8M | Buy |
955,402
+9,940
| +1% | +$216K | 0.09% | 171 |
|
2018
Q2 | $14.4M | Buy |
945,462
+31,937
| +3% | +$487K | 0.06% | 188 |
|
2018
Q1 | $18M | Buy |
913,525
+423,525
| +86% | +$8.34M | 0.08% | 178 |
|
2017
Q4 | $7.66M | Buy |
+490,000
| New | +$7.66M | 0.04% | 211 |
|